Genprex Inc. (NASDAQ: GNPX) CMO Discusses Recent Company Announcements in Bell2Bell Podcast Episode
Genprex Chief Medical Officer, Dr. Mark Berger, was featured in a recent Bell2Bell Podcast episode, where he discussed the company’s…
Blog
Cepton, Inc. (NASDAQ: CPTN) Expands Collaboration with NVIDIA, Releases New Financial Update Revealing Progress on Volume Production
Cepton integrated Vista-X120 Plus lidar into NVIDIA Omniverse platform to enable real-time simulation and 3D visualization to streamline lidar deployment…
QualityStocksNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) to be Showcased at Upcoming Tesla Event
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, has announced that its…
QualityStocksNewsBreaks – CISO Global Inc. (NASDAQ: CISO) Reshaping the Concept of Cybersecurity
CISO Global Inc. (NASDAQ: CISO), an industry leading cybersecurity and compliance provider, understands that, to win the cyber war, a…
QualityStocksNewsBreaks – Canada Nickel Company Inc.’s (TSX.V: CNC) (OTCQX: CNIKF) Texmont Project ‘Continues to Deliver Excellent Results’
Canada Nickel (TSX.V: CNC) (OTCQX: CNIKF) today announced the initial results from preliminary metallurgical test work on the first set…
QualityStocksNewsBreaks – Fintech Ecosystem Development Corp. (NASDAQ: FEXD) Announces Third Deadline Date Extension to Complete Initial Business Combination
Fintech Ecosystem Development Corp. (NASDAQ: FEXD) today announced that its board of directors has decided to extend the date by…
QualityStocksNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) 755-201-EB Trial Demonstrates Clinically Important Results
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs,…
Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Additional Findings in Diabetes Animal Study and Two Other R&D Programs
Diabetes – Blood glucose levels reduced by 19.9% with patented DehydraTECH(TM) processed CBD Epilepsy – Lower dosages of DehydraTECH-CBD were…
QualityStocksNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) Closes First $3.5M Tranche of Non-Brokered Private Placement
FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a leading green ammonia company, yesterday announced its completion of the first tranche of its…
BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Gains Exclusive Development and Commercialization License from Max Planck for biobetter Anti-IL-17 Antibody
BiondVax just signed an exclusive worldwide license agreement with the Max Planck Society to develop and commercialize innovative NanoAb therapeutics…